» Articles » PMID: 3518409

Clinical and Portal Hemodynamic Features in Cirrhotic Patients Having a Large Spontaneous Splenorenal And/or Gastrorenal Shunt

Overview
Specialty Gastroenterology
Date 1986 Jun 1
PMID 3518409
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Clinical and portal hemodynamic features in 28 cirrhotic subjects with a large spontaneous spleno- and/or gastrorenal shunt were studied in comparison with 30 control cirrhotic cases without such collaterals. Forty-six percent of the former had chronic hepatic encephalopathy, but none of the latter was encephalopathic. These patients with large renal shunts were divided into those with and those without encephalopathy. Large esophageal varices were significantly less common in patients with a large shunt and encephalopathy compared with those who had a large shunt but no encephalopathy, and the control. But there was no significant difference of past variceal bleeding among these three groups. In all those with encephalopathy, part of superior mesenteric venous blood was shunting through these collaterals into the left renal vein or inferior vena cava, but the same was not demonstrable in patients with a large shunt and no encephalopathy and control cirrhotics. In the chronic encephalopathic, portal venous flow was estimated to be less than one-half of that in control cirrhotics, and the portion of superior mesenteric venous blood that was flowing hepatofugally through a large shunt into the left renal vein seemed about the same or greater than the portal venous flow. Thus, a large spontaneous spleno- and/or gastrorenal shunt might prevent development of large esophageal varices but not variceal hemorrhage and it increased a risk of chronic hepatic encephalopathy.

Citing Articles

Safety and efficacy of interventional embolization in cirrhotic patients with refractory hepatic encephalopathy associated with spontaneous portosystemic shunts.

Ke Q, He J, Cai L, Lei X, Huang X, Li L Sci Rep. 2024; 14(1):14848.

PMID: 38937539 PMC: 11211343. DOI: 10.1038/s41598-024-65690-1.


Interventional embolisation for patients with cirrhosis and recurrent or persistent hepatic encephalopathy related to spontaneous portosystemic shunts: protocol for a prospective, non-randomised controlled study.

Ke Q, Lin T, Lei X, Weng X, He J, Huang X BMJ Open. 2024; 14(2):e081194.

PMID: 38346880 PMC: 10862332. DOI: 10.1136/bmjopen-2023-081194.


To evaluate the prevalence of spontaneous portosystemic shunts in decompensated cirrhosis patients and its prognostic significance.

Kothari R, Khanna D, Kar P Indian J Gastroenterol. 2023; 42(5):677-685.

PMID: 37642937 DOI: 10.1007/s12664-023-01393-1.


Old and New Precipitants in Hepatic Encephalopathy: A New Look at a Field in Continuous Evolution.

Bellafante D, Gioia S, Faccioli J, Riggio O, Ridola L, Nardelli S J Clin Med. 2023; 12(3).

PMID: 36769836 PMC: 9917479. DOI: 10.3390/jcm12031187.


The Link between Gut Microbiota and Hepatic Encephalopathy.

Won S, Oh K, Gupta H, Ganesan R, Sharma S, Jeong J Int J Mol Sci. 2022; 23(16).

PMID: 36012266 PMC: 9408988. DOI: 10.3390/ijms23168999.